Our research and development locations
Bristol Myers Squibb's drug discovery and development work takes place across a network of state-of the-art facilities worldwide. For information about a specific Bristol Myers Squibb facility, click the link from the list below or view the complete list of our worldwide locations.
- Bangalore, India
- Boudry, Switzerland
- Brisbane, California
- Cambridge, Massachusetts
- Hyderabad, India
- Lawrenceville, New Jersey
- Madison, New Jersey
- New Brunswick, New Jersey
- Princeton Pike, New Jersey
- Redwood City, California
- San Diego, California
- Seattle, Washington
- Seville, Spain
- Shanghai, China
- Summit, New Jersey
- Tokyo, Japan
Bangalore, India
The Biocon Bristol Myers Squibb Research & Development Center (BBRC) is a collaboration between Bristol Myers Squibb and Syngene International, a Biocon-group company, and is based in Bangalore, India. Fully operational since 2009, the site is involved in target identification, lead discovery and lead optimization all the way through to early stage pharmaceutical development and clinical biomarkers R&D.
Boudry, Route de Perreux 1, Switzerland
The BMS major global collaboration hub in Boudry is located in the canton of Neuchatel, in the French-speaking western part of Switzerland, just outside urban centers like Lausanne, Geneva and Bern. With employees from more than 60 nationalities, Boudry is an important part of the global R&D organization with key representation of clinical development, drug safety and regulatory as well as medical, commercial and enabling functions, supporting global markets. It houses a state-of-the-art small molecule manufacturing and testing facility, producing six different oral drugs.
Brisbane, California
Located in the heart of the San Francisco Bay Area’s life sciences cluster, our Brisbane R&D campus is home to teams spanning early research to early and late clinical development. With a proven track record of developing innovative solutions, scientific teams in Brisbane have the freedom to collaborate across many scientific disciplines and therapeutic areas to drive meaningful advances for patients with serious unmet need.
Cambridge, Massachusetts
Located at the epicenter of innovation in the Greater Boston area, Bristol Myers Squibb’s state-of-the-art R&D site at Cambridge Crossing brings together pillars of discovery, development and data across oncology, neuroscience and immunology. The passion of hundreds of scientists in Cambridge, coupled with Bristol Myers Squibb’s broad scope of research and development capabilities around the world, is contributing to one of the most promising pipelines in the industry.
Hyderabad, India
Bristol Myers Squibb Hyderabad is a key contributor to the company’s drive to harness the depth and breadth of its pipeline to help patients prevail over serious diseases by building sustainable and innovative solutions. The development organization in Hyderabad helps build important capabilities that support several important stages of the drug lifecycle, including clinical development, clinical operations, regulatory, biometrics and safety.
Lawrenceville, New Jersey
The Lawrenceville campus serves as Bristol Myers Squibb's Research & Development headquarters. Here, scientists discover and develop medicines in the areas of cancer, immunology and cardiovascular diseases.
Madison, New Jersey
Opened in 2023, the R&D site located at Giralda Farms in Madison contributes to advancing Bristol Myers Squibb’s pipeline with teams collaborating across research and drug development.
New Brunswick, New Jersey
Purchased in 1905 when E.R. Squibb & Sons relocated operations from Brooklyn, New York, R&D teams in New Brunswick lead nonclinical safety studies of development candidates. They collaborate closely with co-located teams focused on product and process development and manufacturing to support clinical trials.
Princeton Pike, New Jersey
The Princeton Pike site houses employees from the commercial teams, their commercialization and late-stage development partners from Research & Development and Global Product Development & Supply, and their enabling function support teams.
Redwood City, California
Located in the San Francisco Bay area’s vibrant Silicon Valley, the Redwood City research facility houses biologics drug discovery activities focused on antibody therapeutics.
San Diego, California
Bristol Myers Squibb’s San Diego footprint includes four R&D facilities near LaJolla and Torrey Pines. Scientists in San Diego focus on the exploration of novel biology and target concepts – such as targeted protein degradation – and complex biologics, aiming to better understand and modulate the biological processes that lead to cancer, neurodegenerative diseases and other diseases with significant unmet needs.
A new, state-of-the-art site set to open in 2026 will bring R&D teams in San Diego together under one location.
Seattle, Washington
Bristol Myers Squibb’s R&D site in Seattle is a hub for the company’s discovery, pipeline development and translational research efforts focused on cell therapy and cancer biology. The site, which includes co-localized teams leading the development of cell therapy manufacturing technologies, serves as an important R&D engine for cell therapy innovation with passionate scientists working to help advance a wide spectrum of next generation approaches to cell therapies and optimize immune cell function in treating hematologic malignancies, solid tumors and autoimmune diseases.
Seville, Spain
Bristol Myers Squibb's Center for Innovation and Translational Research Europe (CITRE) R&D site in Seville, Spain, is a capability center that brings together teams from our global informatics and predictive sciences, early clinical development and thematic research center organizations to contribute to Bristol Myers Squibb research efforts worldwide.
The site houses computational, clinical and biology research teams as well as dedicated computational research infrastructure and laboratory facilities.
Shanghai, China
Drug development teams based at Bristol Myers Squibb’s Wheelock Square location in Shanghai’s Puxi commercial heart are connected to commercial and access and medical affairs colleagues to bring innovative medicines to patients in China.
Summit, New Jersey
Bristol Myers Squibb’s site in Summit brings together colleagues in translational medicine for hematology and diagnostics, nonclinical research, clinical pharmacology, predictive sciences and clinical development to advance new medicines for patients.
Tokyo, Japan
With a presence in Japan spanning over 65 years, Bristol Myers Squibb relocated its Tokyo site to the prominent business center of Otemachi in 2022. Teams in Tokyo collaborate with colleagues globally to support Bristol Myers Squibb’s clinical trial network in Japan.